The Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% over the forecast period, owing to the rising healthcare expenditure, disposable income of individuals, increasing popularity of biologics and better healthcare access. Increase in the number of autoimmune and respiratory diseases, new drugs in development pipeline and increased usage of OTC NSAIDs are the major factors driving the Asia-Pacific anti-inflammatory market. Moreover, increasing awareness of anti-inflammatory biologics and favorable government initiatives in the Asia-Pacific region are expected to drive the market during the analysis period. Factors, such as side effects of anti-inflammatory drugs and uncertain patent legislations, i.e., compulsory licensing in India would continue to impede the market growth.
The industry is segmented on the basis of indication, drug class and geography. The indications considered in this report include arthritis, respiratory diseases, multiple sclerosis, psoriasis, inflammatory bowel disease and other inflammatory diseases. Among indications, arthritis was the dominant segment accounting for 41.3% of the APAC anti-inflammatory therapeutics market in 2014 and holds potential for growth during the forecast period. Anti-inflammatory biologics are the most preferred drugs for treatment of arthritis.
On the basis of drug class, the market is segmented into anti-inflammatory biologics, non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Anti-inflammatory biologics holds the largest share among drug classes accounting for around 50% share of the market, and is expected to grow rapidly during the forecast period. Geographically, the market is segmented into six countries namely Japan, China, India, Australia, South Korea, Indonesia and others. Among these countries, Japan holds the largest share in the industry; however, China is expected to exhibit the fastest growth during the forecast period. Major market players have adopted strategies such as collaborations, indication expansions and product launches to expand their market presence. In 2014, Novartis got marketing approval for the drug Cosentyx (secukinumab) in Japan for the treatment of psoriatic arthritis. The company has filed new patents to overcome the issues of patent expiries of their existing drugs and to gain a prominent market share. The key companies profiled in this report are Pfizer, Inc., AbbVie, Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & CO., Inc., Novartis AG, F. Hoffmann-La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen.
KEY MARKET SEGMENTS
The Asia-Pacific Anti-inflammatory Therapeutics Market is segmented below:
BY DRUG CLASS
SIMILAR MARKET STUDIES
The China Human Immunoglobulin (pH4) for Intravenous Injection Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Human Immunoglobulin (pH4) for Intravenous Injection industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Human ...
July 2016 | $3200 | View Details >>
Summary Ocata Therapeutics, Inc. (Ocata) formerly known as Advanced Cell Technology, Inc. is a clinical stage biotechnology company that specializes in regenerative medicine. The company develops and commercializes for various ophthalmological disorders including Stargardt’s macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. It key development programs include RPE Cell ...
July 2016 | $250 | View Details >>
ICD Research's "Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
March 2012 | $125 | View Details >>
The Global Double Medical Pendant Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Double Medical Pendant industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description ...
March 2017 | $2800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research